Uterine leiomyoma: Clinical sciences

Last updated: January 30, 2025

Uterine leiomyoma: Clinical sciences

Women's Health - Midterm

Women's Health - Midterm

Cervical cancer
Breast cancer
Ovarian germ cell tumors
Endometrial hyperplasia
Uterine fibroid
Endometriosis
Amenorrhea: Pathology review
Breast cancer: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Menstrual cycle
Estrogen and progesterone
Anatomy and physiology of the female reproductive system
Ectopic pregnancy
Miscarriage
Pelvic inflammatory disease
Ectopic pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Emergency contraception: Clinical sciences
Reversible contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Endometriosis: Clinical sciences
Adnexal torsion: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Approach to nipple discharge: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Breast abscess: Clinical sciences
Breast papilloma: Clinical sciences
Fibroadenoma: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast cyst: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Endometrial intraepithelial neoplasia (hyperplasia) and carcinoma: Clinical sciences
Adenomyosis: Clinical sciences
Uterine leiomyoma: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Uterine leiomyomas, also known as fibroids, are benign, solid neoplasms made up of smooth muscle cells and fibroblasts. They can vary in size and location in the uterus, including intramural that are found within the width of the myometrium; submucosal that grow towards the mucosa of the uterus; subserosal that are found near the outer layer or serosa of the uterus; and pedunculated fibroids that grow on a stalk out of the uterine walls, either inside and outside the uterus.

Uterine leiomyomas are very common, and the majority of women have at least one by menopause. They are often asymptomatic, but symptomatic leiomyomas can cause a variety of issues, such as heavy bleeding and pelvic pressure or pain. In fact, leiomyoma is one of the important causes of abnormal uterine bleeding or heavy menstrual bleeding, which can be easily remembered with the mnemonic PALM COEIN. This stands for Polyps, Adenomyosis, Leiomyoma, Malignancy, Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, and Not yet classified. Additionally, leiomyomas can cause infertility in some patients, and depending on their location in the uterus, they can even be associated with recurrent pregnancy loss.

When assessing a patient who presents with a chief concern suggesting they have a uterine leiomyoma, your first step is to obtain a focused history and physical. Patients may report prolonged or heavy menstrual bleeding; anemia; or symptoms of uterine enlargement such as pelvic pressure or pain, urinary frequency, and constipation. While obtaining a history, pay attention to certain risk factors for uterine leiomyomas, such as premenopausal status, a family history of leiomyomas, increasing interval since last birth, hypertension, and obesity. On a physical exam you may note an enlarged uterus or an irregular uterine contour.

Here’s a clinical pearl! Black individuals have a 2 to 3 times higher rate of having uterine leiomyomas compared to white individuals. Due to racial disparities and social determinants of health, black patients also develop leiomyomas earlier and have worse clinical symptoms including higher rates of anemia and larger uteri at the time of diagnosis.

Now, back to your patient! Based on your history and physical exam findings, you should suspect uterine leiomyoma and order a pelvic ultrasound. If there is no evidence of a leiomyoma on ultrasound, you should consider an alternative diagnosis. Since there are multiple types of leiomyomas, ultrasound findings can vary, but generally, you’ll see a smooth and regular myometrial mass.

Let's talk about the different types of leiomyomas. The International Federation of Gynecology and Obstetrics, or FIGO, created a standardized leiomyoma subclassification system that’s used to describe the location of leiomyomas in the uterus. Submucosal leiomyomas are numbered 0 to 2. Category 0 is intracavitary pedunculated, category 1 is less than 50% intramural and category 2 greater than or equal to 50% intramural. Categories 3 and 4 are both intramural but 3 contacts the endometrium. Subserosal leiomyomas are numbered 5 to 7: category 5 is greater than or equal to 50% intramural, category 6 is less than 50% intramural and category 7 is subserosal pedunculated. Category 8 encompasses others, which includes cervical leiomyomas. Keep in mind that you can also have a leiomyoma that prolapses through the cervix!

Here’s another clinical pearl! A standard pelvic ultrasound is a helpful tool, but it can be hard to distinguish all the categories of leiomyomas. A subserosal pedunculated leiomyoma is generally best diagnosed with a pelvic ultrasound, while others need further workup. If you are suspicious of a submucosal leiomyoma, a sonohysterogram can be a useful tool. This is performed by injecting a small amount of saline into the uterine cavity during a transvaginal ultrasound to open up the endometrial cavity and inspect the contours of the endometrium. Hysteroscopy, where a camera is inserted into the endometrial cavity along with saline, can be used to visually diagnose and treat submucosal leiomyomas too. An MRI can be used for surgical planning to map out a large fibroid uterus.

Okay, now that you’ve diagnosed leiomyoma, let's talk about treatment options! The main categories for management are expectant, medical, procedural, and surgical. It's important to discuss all the options with your patient and make a treatment plan based on your patient's goals.

Sources

  1. "ACOG practice bulletin no. 228. Management of Symptomatic Uterine Leiomyomas" Obstet Gynecol (2021)
  2. "ACOG committee opinion no. 822. Uterine Morcellation of Presumed Leiomyomas" Obstet Gynecol (2021)